8 research outputs found
Halitosis: prevalence, risk factors, sources, measurement and treatment – a review of the literature
Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study.
This phase II, open-label, randomised study evaluated whether patients with metastatic pancreatic cancer receiving erlotinib/gemcitabine derived survival benefits from increasing the erlotinib dose.SCOPUS: ar.jinfo:eu-repo/semantics/publishe
The Polish School of Argumentation:A Manifesto
Building on our diverse research traditions in the study of reasoning, language and communication, the Polish School of Argumentation integrates various disciplines and institutions across Poland in which scholars are dedicated to understanding the phenomenon of the force of argument. Our primary goal is to craft a methodological programme and establish organisational infrastructure: this is the first key step in facilitating and fostering our research movement, which joins people with a common research focus, complementary skills and an enthusiasm to work together. This statement—the Manifesto—lays the foundations for the research programme of the Polish School of Argumentation